| Friday, December 04, 2009 |
| 08:16 AM |
|
Medcohealth Solutions (MHS) 12/4/09 PriceWatch Alert Could Hit 22.31% Return
Medcohealth Solutions (NYSE: MHS) closed yesterday at $63.48. So far the stock has hit a 52-week low of $36.46 and 52-week high of $64.29. Medcohealth Solutions stock has been showing support around 62.89 and resistance in the 64.53 range. Technical indicators for the stock are Bullish and S&P gives MHS a very positi...(Click the story link or go to http://www.marketintelligencecenter.com for the full story)
|
MarketIntelligenceCe...
|
| Thursday, December 03, 2009 |
| 08:07 AM |
|
Medcohealth Solutions (MHS) 12/3/09 PriceWatch Alert With Support Around $62.50
Medcohealth Solutions (NYSE: MHS) closed yesterday at $63.96. So far the stock has hit a 52-week low of $36.46 and 52-week high of $64.29. Medcohealth Solutions stock has been showing support around 62.50 and resistance in the 65.02 range. Technical indicators for the stock are Bullish and S&P gives MHS a very positi...(Click the story link or go to http://www.marketintelligencecenter.com for the full story)
|
MarketIntelligenceCe...
|
| Wednesday, December 02, 2009 |
| 10:16 AM |
|
This Recession Is Gonna Make Me Rich (Again)
The best time to buy is in down markets.
|
Fool.com Headlines
|
| 08:29 AM |
|
Medcohealth Solutions (MHS) 12/2/09 PriceWatch Alert With 5.65% Downside Protection
Medcohealth Solutions (NYSE: MHS) closed yesterday at $63.68. So far the stock has hit a 52-week low of $36.46 and 52-week high of $64.00. Medcohealth Solutions stock has been showing support around 62.84 and resistance in the 64.42 range. Technical indicators for the stock are Bullish and S&P gives MHS a very positi...(Click the story link or go to http://www.marketintelligencecenter.com for the full story)
|
MarketIntelligenceCe...
|
| 06:55 AM |
|
AmerisourceBergen Corporation performance impressive since earnings; ABC, OCR, CAH, MHS
| Earnings releases can make investing tricky. Many traders try to time trades based on earnings filings, but usually find such trading is difficult and dangerous. It is often better to take a look at how the market has reacted to a company’s results a few weeks after the initial announcement. AmerisourceBergen Corporation (ABC) released its earnings announcement on 11/03. The company reported a change in quarter-over-quarter sales of 9.08% and posted an EPS (trailing twelve months) of 1.68. {loadposition link_newslink1} | | | | {loadposition livevideopromo} | | | | | | {loadposition homeaccordion2} | | | {loadposition contentad} | | | | | By now the market has had time to settle in and look closely at the numbers. A stock’s performance in the few weeks following an announcement, compared to other stocks in its industry, the industry as a whole, and market as a whole, really tells you how investors and analysts felt about the announcement. Compared to the rest of the “Drugs Wholesale” industry Since the ABC announcement (about 30 days ago), the stock has posted a 12.55% gain. Over that same period, the stock’s industry, Drugs Wholesale, saw a 11.44% gain. That’s a difference of 9.70% that ABC has outperformed its industry as a whole since the earnings announcement. Small differences aren’t significant, but when the spread is large it indicates the stock is either much more or much less favored than its group as a whole. Compared to peers Another way to gauge performance is look at a stock compared to other stocks in its industry with similar market caps. ABC peer Omnicare Inc. (OCR) has seen a 8.35% stock price gain over about the last month, while another peer, Cardinal Health, Inc. (CAH) saw a 14.54% gain. So with a return of 12.55%, AmerisourceBergen Corporation outgained OCR and under-performed CAH’s price performance over the last month. MedcoHealth Solutions Inc. (MHS) is one of the largest stocks in the industry in terms of market cap, and over the same period has returned 13.47% in price. Compared to the S&P 500 Index Finally, let’s see how AmerisourceBergen Corporation stock performance compares to the rest of the market by looking at it compared to the Standard & Poor’s 500 Index (.INX). Since 11/03, the S&P 500 index has returned around 6.1%, and again, ABC saw about a 12.55% gain during that time. Not bad. So by putting the returns in context by these comparisons, we can see how a stock’s performance since earnings really measures up and make our investing decisions on ABC accordingly. {loadposition link_nowtime} {loadposition followus} |
|
News Feed
|
| Tuesday, December 01, 2009 |
| 02:32 PM |
|
Medco Health December 60 puts active on low volatility
See the rest of the story here.
Theflyonthewall.com is Wall Street's specialist in breaking equity news. Veteran traders build a proprietary feed of news that's faster and more relevant than any other source. Try us for free and discover for yourself.
|
theflyonthewall.com
|
| 08:37 AM |
|
Medcohealth Solutions (MHS) 12/1/09 PriceWatch Alert Support Down To $61.62
Medcohealth Solutions (NYSE: MHS) closed yesterday at $63.16. So far the stock has hit a 52-week low of $36.46 and 52-week high of $63.39. Medcohealth Solutions stock has been showing support around 61.62 and resistance in the 64.16 range. Technical indicators for the stock are Bullish and S&P gives MHS a very positi...(Click the story link or go to http://www.marketintelligencecenter.com for the full story)
|
MarketIntelligenceCe...
|
| 08:08 AM |
|
Coventry, Medco partner to develop personalized care program
See the rest of the story here.
Theflyonthewall.com is Wall Street's specialist in breaking equity news. Veteran traders build a proprietary feed of news that's faster and more relevant than any other source. Try us for free and discover for yourself.
|
theflyonthewall.com
|
| 08:00 AM |
|
Coventry and Medco Partner to Develop Personalized Care Program to Reduce Hospitalizations among the Medicare Population
|
PR Newswire
|
| Monday, November 30, 2009 |
| 12:09 PM |
|
Medcohealth Solutions (MHS) NewsBite - MHS Hits 52-Week High
Medcohealth Solutions (NYSE: MHS) hit a new 52-Week high of $63.39 so far today. Currently the stock is up $0.59 (0.95%) to $63.08 on 1,136,994 shares traded. Today's high is up $26.62 from a 52-We...(Click the story link or go to http://www.marketintelligencecenter.com for the full story)
|
MarketIntelligenceCe...
|
| 09:07 AM |
|
3 Stocks That Just Make Sense
Throw away your complex computer models and charting software; these three stocks just plain make sense.
|
Fool.com Headlines
|
| 08:11 AM |
|
Medcohealth Solutions (MHS) 11/30/09 PriceWatch Alert Targets 4.80% Downside Protection
Medcohealth Solutions (NYSE: MHS) ended the last trading session at $62.49. So far the stock has hit a 52-week low of $36.46 and 52-week high of $63.32. Medcohealth Solutions stock has been showing support around 60.40 and resistance in the 64.16 range. Technical indicators for the stock are Bullish and S&P gives MHS a ...(Click the story link or go to http://www.marketintelligencecenter.com for the full story)
|
MarketIntelligenceCe...
|
| 07:49 AM |
|
The Real Problem With the Public Health-Care Plan
It's the morphing part that should scare you.
|
Fool.com Headlines
|
| Sunday, November 29, 2009 |
| 11:56 PM |
|
(MHS) Medco Health Solutions Beats – Provides Strong Outlook
Medco Health Solutions (MHS) reported third quarter earnings of 75 cents per share, well above the Zacks Consensus Estimate of 71 cents as well as 63 cents reported in the year-ago period. Medco, the largest pharmacy benefit manager (PBM) recorded an increase of 17.8% in revenues which came in at $14.8 billion primarily driven by [...]
(MHS) Medco Health Solutions Beats – Provides Strong Outlook
|
Stock Blog Hub
|
| Friday, November 27, 2009 |
| 09:30 AM |
|
Medco Beats, Provides Strong Outlook – Analyst Blog
Medco Health Solutions ( MHS) reported third quarter earnings of 75 cents per share, well above the Zacks Consensus Estimate of 71 cents as well as 63 cents reported in the year-ago period. Medco, the largest pharmacy benefit manager (PBM) recorded an increase of 17.8% in revenues which came in at $14.8 billion primarily driven by contributions from significant new client wins, as well as price inflation on brand-name drugs, partially offset by higher volumes of lower-priced generic drugs.
Revenues from MHS’ specialty pharmacy segment, Accredo Health Group increased 19.2% to $2.4 billion primarily due to significant addition of new clients and organic growth.
The reported quarter has been quite significant for Medco. The huge acceptance of generic drugs (they have higher margins for PBMs compared to branded drugs) is evident from the fact that the generic dispensing rate increased 3.3% year over year to a record 67.7%. In addition, both the mail-order and retail generic dispensing rates increased 230 basis points to 58.1% and 300 basis points to 69.4%, respectively.
Medco records more than 50% of its revenues from retail products. For the third quarter, out of $14.59 billion of net product revenues, retail products accounted for $9 billion with mail-order products accounting for the rest. Both retail and mail order products recorded an increase of 29.9% and 2.3%, respectively compared to the same period last year. Increased retail product sales have brought down the gross margin to 6.1% from 6.5% in the comparable period while the more profitable mail-order volume dropped by 2.3%.
At the end of the third quarter, Medco had $2 billion of cash balance after paying down $400 million of short term debt. Cash flow from operating activities increased considerably during the period – $2.5 billion compared to $797.2 million in the third quarter of 2008.
Based on the robust performance of all the segments, Medco raised its 2009 earnings guidance. The company revised its earnings guidance to $2.80 - $2.82 per share (earlier guidance: $2.76-$2.81), an increase of 20-21% compared to the year ago period.
In addition, Medco announced its outlook for 2010. The company expects earnings per share in the range of $3.28-$3.38, an increase of 16-21% compared to the new guidance for 2009. We believe a strong balance sheet along with significant new client wins in addition to retention of existing clients enabled the company to present a robust outlook for 2010. Read the full analyst report on "MHS"Zacks Investment Research
|
Stock Market News & ...
|
| 08:24 AM |
|
Medcohealth Solutions (MHS) PriceWatch Alert for November 27, 2009
Medcohealth Solutions (NYSE: MHS) closed yesterday at $63.31. So far the stock has hit a 52-week low of $36.46 and 52-week high of $63.32. Medcohealth Solutions stock has been showing support around 62.41 and resistance in the 63.77 range. Technical indicators for the stock are Bullish and S&P gives MHS a very posit...(Click the story link or go to http://www.marketintelligencecenter.com for the full story)
|
MarketIntelligenceCe...
|
| Thursday, November 26, 2009 |
| 08:45 AM |
|
Medcohealth Solutions (MHS) PriceWatch Alert for November 27, 2009
Medcohealth Solutions (NYSE: MHS) closed yesterday at $63.31. So far the stock has hit a 52-week low of $36.46 and 52-week high of $63.32. Medcohealth Solutions stock has been showing support around 62.41 and resistance in the 63.77 range. Technical indicators for the stock are Bullish and S&P gives MHS a very posit...(Click the story link or go to http://www.marketintelligencecenter.com for the full story)
|
MarketIntelligenceCe...
|
| Wednesday, November 25, 2009 |
| 08:29 AM |
|
Medcohealth Solutions (MHS) 11/25/09 PriceWatch Alert Support Down To $62.03
Medcohealth Solutions (NYSE: MHS) closed yesterday at $62.92. So far the stock has hit a 52-week low of $36.46 and 52-week high of $63.07. Medcohealth Solutions stock has been showing support around 62.03 and resistance in the 63.51 range. Technical indicators for the stock are Bullish and S&P gives MHS a very posi...(Click the story link or go to http://www.marketintelligencecenter.com for the full story)
|
MarketIntelligenceCe...
|
| Tuesday, November 24, 2009 |
| 08:07 AM |
|
Medcohealth Solutions (MHS) 11/24/09 PriceWatch Alert Up To 1.99% Downside Protection
Medcohealth Solutions (NYSE: MHS) closed yesterday at $62.70. So far the stock has hit a 52-week low of $36.46 and 52-week high of $63.00. Medcohealth Solutions stock has been showing support around 60.91 and resistance in the 63.89 range. Technical indicators for the stock are Bullish and S&P gives MHS a very posi...(Click the story link or go to http://www.marketintelligencecenter.com for the full story)
|
MarketIntelligenceCe...
|
| Monday, November 23, 2009 |
| 10:46 AM |
|
Walking in Peter Lynch's Shoes
How Harry Lange is preparing Fidelity's Magellan Fund for inflation.
|
Fool.com Headlines
|
| |
More All For MHS
|
|